Molecular diagnoses of century-old childhood tumours reveals cancer causing mutations

24 May 2017, 2:29 p.m.

Archived tumour samples

A collection of 100-year old tumour samples held at Great Ormond Street Hospital (GOSH) has helped pinpoint the genetic mutations that cause some of the rarest childhood cancers.

NIHR Great Ormond Street BRC-theme lead Professor Neil Sebire worked with colleagues at the Wellcome Trust Sanger Institute to sequence DNA from tumour samples that had been preserved in blocks of paraffin wax since the 1920s. The team then cross-referenced the samples with archived patient case books which contain information about the patient’s symptoms, condition and diagnosis. Together this information enabled researchers to identify several cancer causing mutations. In one case of the blood vessel cancer (cellular capillary haemangioma) researchers found a mutation in the ASXL1 gene which had not previously been seen in solid tumours.

This proof of principle study shows that it is possible to obtain genetic information from preserved tissue. It also demonstrates the potential of this approach in understanding the genetic basis of rare childhood cancers where the very low incidences mean contemporary tissue samples are scarce

The research was published in a letter to Lancet Oncology  and featured on Radio 4's Inside Science, The Guardian and Nature News.

Engineered tissue offers hope for children born with ‘missing’ food pipe

Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown oesophagus - the food pipe - shown to safely replace a full section of the organ and restore normal function, including swallowing, in

GOSH celebrates Rare Disease Day 2026 with local community

GOSH specialises in rare disease research and to celebrate, we recently invited two local North London Year 4 classes to join us for the day to learn about how we care for patients with rare diseases.

Professor Francesco Muntoni wins prestigious research prize

Professor Francesco Muntoni, GOSH Paediatric Neurology Consultant, has been awarded the 2026 Novo Nordisk Prize in recognition of his pioneering work transforming the outlook for children with Duchenne muscular dystrophy (DMD).

GOSH secures £1.4m in NIHR capital equipment funding to boost research capability

This investment will significantly strengthen our research infrastructure and enhance our ability to deliver world‑leading paediatric research across the whole hospital.